Jason Summa

Senior Director, Clinical Science

Jason brings more than 25 years of leadership in clinical development and clinical operations across oncology and multiple therapeutic areas. Throughout his career, he has guided programs from early discovery through late-stage development, building integrated strategies that align clinical, regulatory, CMC, and operational teams to advance complex programs efficiently. Jason has led global development initiatives, overseen regulatory submissions, and built portfolio governance frameworks that help organizations move programs through critical development inflection points with clarity and speed. At K36, Jason will help strengthen our clinical execution as we continue advancing our epigenetic oncology programs for patients with high-risk cancers